Skip to content

Efficacy of Audio-Visual-Perception-Enhancement (AVWF®) Method in Chronic Pain Patients

Efficacy of Audio-Visual-Perception-Enhancement (AVWF®) Method in Chronic Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03776019
Enrollment
57
Registered
2018-12-14
Start date
2019-02-15
Completion date
2019-12-20
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Stress

Keywords

Pain, Stress, AVWF, Audio-Visual-Perception-Enhancement

Brief summary

It is anticipated that Audio-Visual-Perception-Enhancement (AVWF®) method leads to pain reduction and a decrease of inflammatory markers in chronic pain patients. Also an improvement of quality of life, self-perceived disability and depression in chronic pain patients is expected.

Interventions

DEVICEAVWF device

The AVWF method utilizes sound modulated music, which is thought to regulate the vagus nerve.

Sponsors

Klinikum Klagenfurt am Wörthersee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* chronic low back pain with a numeric rating scale of pain \>= 4 for \> 6 month * patients \>18 years

Exclusion criteria

* psychosis * drug addiction * pension process * pregnant women * epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Change in Numeric Rating Scale of Pain SeverityChange from baseline Numeric Rating Scale of Pain Severity after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionValidated 11 pt scale 0-10, to evaluate a patient's current severity of pain. A rating of 0 indicates no pain while 10 indicates the worst pain imaginable. A score of 4 or above is considered a clinically significant pain Level.

Secondary

MeasureTime frameDescription
Hospital Anxiety and Depression ScaleChange from baseline Hospital Anxiety and Depression Scale after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionAnxiety and depression is evaluated by the the Hospital Anxiety and Depression Scale.It contains 14 items describing symptoms of depression (7 items) and anxiety (7 items). It was developed to identify anxiety and depression in non-psychiatric medical outpatients. Each item on the HADS is scored from 0 (no problem) to 3 (maximum distress).
Pittsburgh Sleep Quality IndexChange from baseline Pittsburgh Sleep Quality Index after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionSelf-report questionnaire that assesses sleep Quality through the measure of 19 individual items, creating 7 components that produce one global score
Health related quality of lifeChange from baseline health related quality of life after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionHealth related quality of life will be measured by euroQol-5D questionnaire. It contains two sections, a descriptive section and a valuation section
Pain Disability IndexChange from baseline Pain Disability Index after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionThe Pain Disability Index is an instrument for measuring the impact that pain has on the ability of a person to participate in essential life activities. Minimal index: 0; maximal index: 70; The higher the index the greater the person's disability due to pain
Salival Cortisol levelChange from baseline salival cortisol level after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionImmunoassay for in vitro quantitative determination of cortisol in saliva
Depression Anxiety Stress ScalesChange from baseline Depression Anxiety Stress Scales after 10 interventions, 4 weeks after the last intervention, and 3 month after the last interventionA 42-item self report instrument designed to measure the three related negative emotional states of depression, anxiety and tension/stress.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026